A detailed history of Qube Research & Technologies LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 112,984 shares of CDNA stock, worth $2.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
112,984
Holding current value
$2.36 Million
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $1.63 Million - $3.84 Million
112,984 New
112,984 $3.53 Million
Q1 2024

May 14, 2024

BUY
$7.96 - $12.37 $794,177 - $1.23 Million
99,771 New
99,771 $1.06 Million
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $12,975 - $16,129
-1,705 Reduced 1.89%
88,665 $753,000
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $37,924 - $75,634
4,295 Added 4.99%
90,370 $825,000
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $615,024 - $1.13 Million
56,528 Added 191.32%
86,075 $982,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $91,333 - $150,079
5,687 Added 23.83%
29,547 $503,000
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $52,905 - $102,557
2,582 Added 12.13%
23,860 $513,000
Q1 2022

May 09, 2022

BUY
$28.19 - $46.6 $599,826 - $991,554
21,278 New
21,278 $787,000
Q4 2021

Feb 01, 2022

SELL
$41.2 - $73.6 $260,631 - $465,593
-6,326 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$59.15 - $91.99 $349,872 - $544,120
-5,915 Reduced 48.32%
6,326 $401,000
Q2 2021

Aug 13, 2021

SELL
$63.02 - $95.11 $112,931 - $170,437
-1,792 Reduced 12.77%
12,241 $1.12 Million
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $808,581 - $1.34 Million
14,033 New
14,033 $956,000
Q3 2020

Nov 12, 2020

SELL
$30.88 - $37.94 $494,882 - $608,026
-16,026 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $303,692 - $567,801
16,026 New
16,026 $568,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.12B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.